Two Raises $100K Funding

Simplifai

Since 2017, Simplifai transforms insurance businesses by optimizing claims processes with Agentic AI. Our Enterprise Grade AI Platform offers the flexibility to build custom AI Agents of varying complexities or employ one of our pre-built Agents for bodily injury, motor, and travel claims.  Whether your focus is on enhancing customer experience, cutting costs, or mitigating risks, our AI Agents adapt to align with your strategies and objectives. By taking over repetitive manual tasks, our Agents empower your teams to concentrate on high-value work, improving both efficiency and customer satisfaction.  As your AI partner, we collaborate closely with you to drive innovation, ensuring that every new feature we release directly addresses your evolving needs. With data privacy, security, and compliance as our top priorities, our fully certified platform ensures your business remains secure and future-ready. Discover more at: https://www.simplifai.ai/

Exabel

Exabel is an end-to-end platform for the organization, analysis, visualization and transformation of alternative data. The Exabel platform is built to enable fundamental investment teams to work with alternative data more effectively by providing the analytical tools for combining foundational, their own and our alternative data partners’ data assets. The explosion in available data is creating a wide gap between the few top-tier finance institutions capable of developing in-house big data technologies, and everybody else. A basic premise for market efficiency and fairness is that investors have equal access to information. However, investors may have full access to information, yet not be equipped to make sense of it.

DoMore Diagnostics

DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. The company is based on prominent international research from leading universities and funded by top Norwegian tech investors.

Gen2 Energy

Gen2 Energy is dedicated to developing, building, controlling and operating an integrated value chain for green hydrogen. The company aims to establish production capacity at large-scale for green hydrogen based on 100 percent renewable energy. We are setting up our main distribution of green hydrogen in liquified form. Gen2 Energy’s mission is to provide Europe with clean green hydrogen. Gen2 Energy lets renewable energy production companies utilize more of their green power, by creating a new distribution chain via green hydrogen. We are determined to open a new market channel for unutilized renewable energy to a new European customer base. The environmental footprint is a key part of Gen2 Energy, and in addition to working towards a zero-emission production line, the company also aims at having minimal emissions in the distribution of green hydrogen.

Enode

Enode’s APIs enable you to instantly connect users’ energy devices — including EVs, solar inverters, home batteries and thermostats — to your app. You can surface data, and then take action with it. Our out-of-the-box algorithms allow you to control and optimize your users’ energy devices. A few lines of code will save you months of integration and ongoing maintenance. We cut the cost and complexity of building energy management apps, so you can focus on what matters: creating user-centric experiences that drive engagement, and accelerate the transition to a sustainable energy system.